The Veriblog

(PODCAST) Staying the Course: Impact of COVID-19 on Rx Decisions

In this Sound Insight Podcast, we invite you to listen to Jim Hickey (Vice President, Client Services) and Jeff Troy (Group Director, Client Services) describe the continued tightrope that physicians navigate in this pandemic, weighing the preference to ‘stay the course’ on existing treatments due to lack of routine monitoring and testing, against concerns about patients’ conditions worsening during this period and the associated long-term impact on patient health.

At Verilogue we are curious about the impact COVID-19 is having on healthcare and communication among patients and providers.  One of our biggest questions revolves around the impact of COVID-19 on treatment decision-making. Specific objectives of interest include:

  • Where and how are physicians from select specialties seeing their patients?
  • How, if at all, is the COVID-19 pandemic impacting decisions to initiate or change treatment?
  • How, if at all, are current treatments impacted by the COVID-19 pandemic? What effect, if any, is there on biologics or immunotherapies?
  • What impact is COVID-19 having on patient monitoring and testing? How, if at all, is this affecting treatment decision-making?

To address these questions, Verilogue examined a blend of in-office dialogue recordings and self-reflections recorded using automated voice response survey. This podcast describes the continued tightrope that physicians navigate in this pandemic, weighing the preference to ‘stay the course’ on existing treatments due to lack of routine monitoring and testing, against concerns about patients’ conditions worsening during this period and the associated long-term impact on patient health.

Best of health,

Verilogue

The insights presented in this content piece were developed through a collaborative effort across Verilogue’s research team

%d bloggers like this: